MyAverix Finance
NS · Pharmaceuticals
Bal Pharma Ltd (BALPHARMA)
Pharmaceuticals & Biotechnology
Bal Pharma Ltd (BALPHARMA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.37B, P/E ratio is 20.28, net margin is 2.6%, dividend yield is 1.40%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BALPHARMA
Bal Pharma Ltd (BALPHARMA) — FAQ
What is Bal Pharma Ltd's market cap?
Bal Pharma Ltd (BALPHARMA) has a reported market cap of $1.37B (data as of 2026-07-10).
What is BALPHARMA's P/E ratio?
The price-to-earnings (P/E) ratio for Bal Pharma Ltd (BALPHARMA) is 20.28 (data as of 2026-07-10).
Does Bal Pharma Ltd pay a dividend?
Bal Pharma Ltd (BALPHARMA) shows a reported dividend yield of 1.40%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Bal Pharma Ltd in?
Bal Pharma Ltd (BALPHARMA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is BALPHARMA listed on?
BALPHARMA is listed on NS.
What is Bal Pharma Ltd's net margin?
Bal Pharma Ltd (BALPHARMA) reports a net margin of 2.6% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.